Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), CVS Health (CVS)
Stifel Nicolaus Keeps Their Buy Rating on IQVIA Holdings (IQV)
Stifel Adjusts Price Target on IQVIA Holdings to $288 From $294
IQVIA Holdings (IQV) has an average rating of outperform and price targets ranging from $245 to $295, according to analysts polled by Capital IQ. Price: 224.25, Change: -2.79, Percent Change: -1.23
IQVIA Holdings Inc. (NYSE:IQV) Q1 2024 Earnings Call Transcript
UBS Adjusts Price Target on IQVIA Holdings to $295 From $300, Maintains Buy Rating
IQVIA Holdings (IQV) has an average outperform rating and a price target range of $250 to $300, according to analysts polled by Capital IQ. Price: 225.61, Change: +3.47, Percent Change: +1.56
Truist Securities Maintains Buy on IQVIA Hldgs, Lowers Price Target to $292
Truist Securities analyst Jailendra Singh maintains IQVIA Hldgs (NYSE:IQV) with a Buy and lowers the price target from $297 to $292.
Here's Why IQVIA Holdings (IQV) Is a Strong Value Stock
Forecasting The Future: 8 Analyst Projections For IQVIA Hldgs
Across the recent three months, 8 analysts have shared their insights on IQVIA Hldgs (NYSE:IQV), expressing a variety of opinions spanning from bullish to bearish.The table below summarizes their rece
Buy Rating Affirmed for IQVIA Holdings Amidst Strong Growth and Resilient Demand
IQVIA Holdings (IQV) Receives a Buy From Truist Financial
IQVIA Holdings Price Target Cut to $245.00/Share From $254.00 by Baird
IQVIA Holdings Price Target Cut to $245.00/Share From $254.00 by Baird
IQVIA Holdings Is Maintained at Neutral by Baird
IQVIA Holdings Is Maintained at Neutral by Baird
Evercore ISI Adjusts Price Target on IQVIA to $250 From $275
IQVIA Holdings (IQV) has an average rating of outperform and price targets ranging from $250 to $300, according to analysts polled by Capital IQ.
Baird: Maintaining the IQVIA Hldgs (IQV.US) rating, adjusted from neutral to neutral, and adjusted the target price from $254.00 to $245.00.
Baird: Maintaining the IQVIA Hldgs (IQV.US) rating, adjusted from neutral to neutral, and adjusted the target price from $254.00 to $245.00.
IQVIA Hldgs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 10.29% Baird $254 → $245 Maintains Neutral 02/27/2024 33.7% Truist Securities $286 → $297 Maint
IQVIA Holdings Inc (IQV) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Iqvia Holdings Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our target to $230 from $233, 18.
Earnings Call Summary | IQVIA Holdings(IQV.US) Q1 2024 Earnings Conference
The following is a summary of the IQVIA Holdings Inc. (IQV) Q1 2024 Earnings Call Transcript:Financial Performance:IQVIA reported Q1 revenue growth of 2.3% on a reported basis, and an increase of 2.9%
IQVIA Holdings Inc (IQV) First Quarter 2024 Earnings: Surpasses Revenue Estimates
IQVIA Holdings Backs 2024 View of Adj EPS $10.95-Adj EPS $11.25 >IQV
IQVIA Holdings Backs 2024 View of Adj EPS $10.95-Adj EPS $11.25 >IQV
No Data